Clinical Trials Logo
  1. Home
  2. Mucositis Oral
  3. NCT03577535

Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients.

Mucositis Oral Clinical Trial

Official title:
Evaluation of ONCOXIN® in Oral Mucositis, Appetite and Body Mass in Cancer Patients. Real World Setting Study.

Clinical Trial Summary

Oral mucositis is one of the most spread side effects of anticancer therapy. It is associated with both chemo- and radiotherapy, decreases QoL, relative dose intensity and leads to nutritive deficiency. Oral mucositis causes secondary infections, increased hospital stay, whereas pain syndrome results in an emotional distress, anorexia and disables natural feeding.

Clinical Trial Description

Primary:

To evaluate the efficacy of ONCOXIN on oral mucositis symptoms in patients who receive chemotherapy and/or radiotherapy.

Secondary:

To evaluate the effects of ONCOXIN on nutritional status in patients who receive chemotherapy and/or radiotherapy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03577535
Study type Interventional
Source Catalysis SL
Contact
Status Completed
Phase Phase 2
Start date November 1, 2017
Completion date July 15, 2018
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT05331131 - Efficacy of Ketamine Mouthwash in the Management of Oral and Pharyngeal Toxicity Associated With Head and Neck Chemoradiotherapy: A Phase 2, Simon 2-stage Trial Phase 2
Not yet recruiting NCT06031012 - Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis Phase 3
Not yet recruiting NCT04080622 - Evaluate the Efficacy of Selenium for the Prevention of Chemotherapy-induced Mucositis During Autologous Stem Cell Transplantation. Phase 3
Recruiting NCT06217224 - Evaluation of Prophylactic Photobiomodulation Therapy in Patients With Osteosarcoma N/A
Completed NCT03416582 - Feasibility Study of a Nurse Intervention to Impact Mucositis Severity and Prevent Dehydration N/A
Recruiting NCT04596410 - Photobiomodulation Protocols in the Analgesia of Chemotherapy-induced Oral Mucositis in Children N/A
Recruiting NCT05278260 - Hydrogen-rich Water and Treatment of Mucositis Caused by Radiation Therapy in Head and Neck Cancer Patients N/A
Recruiting NCT05308732 - Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy Phase 1
Completed NCT00293462 - GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Undergoing Radiation Therapy for Head and Neck Cancer Phase 3
Recruiting NCT05926297 - Treatment of Peri-implant Mucositis by Sodium Hypochlorite Gel and Cross-linked Hyaluronic Acid Gel N/A
Recruiting NCT04671862 - Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis N/A
Recruiting NCT05926557 - Treatment of Peri-implant Mucositis by Application of a Spermidine-based Gel N/A
Completed NCT04187222 - Effect of Probiotic Use Bifidobacterium Animalis Subsp. Lactis in Peri-implant Mucositis Phase 3
Completed NCT05307445 - Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy N/A
Completed NCT05214495 - Omega-3 Hydrogel and Prevention of Oral Mucositis Phase 2/Phase 3
Not yet recruiting NCT04303312 - Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis Phase 3
Recruiting NCT03983369 - Low-level Laser Therapy in the Prevention of Chemotherapy-induced Mucositis in Children and Young Adults Phase 3
Completed NCT06049511 - Oral Self Care Protocol and Oral Mucositis N/A
Not yet recruiting NCT05224882 - Chemotherapy Oral Manifestations and Dental Awareness Among Parents
Active, not recruiting NCT03461354 - MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer N/A